Redmile as of Sept. 30, 2016
Portfolio Holdings for Redmile
Redmile holds 51 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 8.9 | $112M | 17M | 6.75 | |
| Seattle Genetics | 7.7 | $96M | 1.8M | 54.01 | |
| Amicus Therapeutics (FOLD) | 7.5 | $94M | 13M | 7.40 | |
| Clovis Oncology | 5.9 | $74M | 2.0M | 36.05 | |
| Gw Pharmaceuticals Plc ads | 5.8 | $73M | 546k | 132.73 | |
| Incyte Corporation (INCY) | 4.5 | $56M | 598k | 94.29 | |
| Penumbra (PEN) | 4.1 | $51M | 673k | 75.99 | |
| Molina Healthcare (MOH) | 3.6 | $45M | 778k | 58.32 | |
| Endologix | 3.5 | $45M | 3.5M | 12.80 | |
| Puma Biotechnology (PBYI) | 3.5 | $44M | 662k | 67.05 | |
| Atara Biotherapeutics | 3.4 | $43M | 2.0M | 21.39 | |
| Prothena (PRTA) | 3.4 | $42M | 702k | 59.97 | |
| Sarepta Therapeutics (SRPT) | 3.1 | $39M | 640k | 61.41 | |
| Agios Pharmaceuticals (AGIO) | 3.1 | $39M | 738k | 52.82 | |
| Centene Corporation (CNC) | 2.5 | $31M | 464k | 66.96 | |
| Ariad Pharmaceuticals | 2.3 | $29M | 2.1M | 13.69 | |
| Boston Scientific Corporation (BSX) | 2.0 | $26M | 1.1M | 23.80 | |
| Nanostring Technologies (NSTGQ) | 2.0 | $25M | 1.2M | 19.98 | |
| Nevro (NVRO) | 1.9 | $24M | 227k | 104.39 | |
| Ophthotech | 1.9 | $23M | 505k | 46.13 | |
| Alder Biopharmaceuticals | 1.8 | $23M | 703k | 32.77 | |
| Wave Life Sciences (WVE) | 1.8 | $23M | 702k | 32.47 | |
| Portola Pharmaceuticals | 1.7 | $21M | 917k | 22.71 | |
| Oxford Immunotec Global | 1.4 | $18M | 1.4M | 12.56 | |
| Chimerix (CMRX) | 1.4 | $18M | 3.2M | 5.54 | |
| Model N (MODN) | 1.4 | $17M | 1.6M | 11.11 | |
| Audentes Therapeutics | 1.2 | $15M | 917k | 16.26 | |
| Neuroderm Ltd F | 1.2 | $15M | 805k | 18.49 | |
| Syros Pharmaceuticals | 0.9 | $12M | 893k | 13.15 | |
| Cytomx Therapeutics (CTMX) | 0.9 | $11M | 715k | 15.68 | |
| Charles River Laboratories (CRL) | 0.8 | $11M | 127k | 83.34 | |
| AstraZeneca (AZN) | 0.8 | $9.5M | 288k | 32.86 | |
| Spectranetics Corporation | 0.7 | $8.4M | 335k | 25.09 | |
| Ironwood Pharmaceuticals (IRWD) | 0.5 | $6.5M | 409k | 15.88 | |
| VCA Antech | 0.5 | $6.4M | 91k | 69.98 | |
| Alexion Pharmaceuticals | 0.4 | $5.6M | 45k | 122.55 | |
| Intra Cellular Therapies (ITCI) | 0.4 | $5.1M | 337k | 15.24 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.4 | $4.8M | 4.0M | 1.19 | |
| Invitae (NVTAQ) | 0.4 | $4.5M | 510k | 8.76 | |
| Fate Therapeutics (FATE) | 0.3 | $4.4M | 1.4M | 3.12 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.3 | $3.8M | 576k | 6.67 | |
| Blueprint Medicines (BPMC) | 0.1 | $818k | 28k | 29.70 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $565k | 188k | 3.01 | |
| UnitedHealth (UNH) | 0.0 | $255k | 1.8k | 140.11 | |
| Biogen Idec (BIIB) | 0.0 | $212k | 677.00 | 313.15 | |
| Humana (HUM) | 0.0 | $246k | 1.4k | 176.98 | |
| Dex (DXCM) | 0.0 | $216k | 2.5k | 87.80 | |
| First Trust Amex Biotech Index Fnd (FBT) | 0.0 | $308k | 3.1k | 99.68 | |
| Achaogen | 0.0 | $155k | 32k | 4.80 | |
| Adverum Biotechnologies | 0.0 | $91k | 22k | 4.09 | |
| Castlight Health | 0.0 | $43k | 10k | 4.20 |
